Purchase Order SPE2DP25V3632
- Not listed
- The U.S. Department of Defense's Medical Supply Chain has awarded a firm fixed-price purchase order totaling $2,010.06 to The Maclean Group LLC for the supply of naloxone hydrochloride. The award, issued on August 13, 2025, with an ultimate completion date of August 28, 2025, represents a small-value procurement with no set-aside designation. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, is an ISO 9001:2015 certified medical and...
- The U.S. Medical Supply Chain within the Department of Defense awarded a firm fixed-price purchase order to The Maclean Group LLC for naloxone hydrochloride, valued at $1,005.03. The contract was executed on August 1, 2025, with an ultimate completion date of August 18, 2025. This award was not set aside for any specific business category. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) headquartered in Sacramento, California, was selected as the prime contractor...
- The U.S. Department of Defense's Medical Supply Chain awarded a purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business (SDVOSB) headquartered in Sacramento, California, for the supply of naloxone hydrochloride. The contract, issued on July 22, 2025, carries a ceiling value of $1,005.03 with a firm fixed price and no set-aside designation, despite the contractor's SDVOSB status. The ultimate completion date is August 6, 2025, with performance at the vendor's...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $2,010.06 firm-fixed-price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the delivery of naloxone hydrochloride. This contract, awarded on October 1, 2024 with an ultimate completion date of October 16, 2024, is not designated as a set-aside. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
- The U.S. Department of Defense's Medical Supply Chain has awarded a firm-fixed-price purchase order contract to The Maclean Group LLC, a service-disabled veteran-owned small business, for the supply of Naloxone Hydrochloride. The $5,025.15 contract has a completion date of May 13, 2024. The Maclean Group is a diversified government contractor that provides a range of products and services, including medical equipment, water treatment systems, and facility maintenance, to various federal agencies...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medical supply. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several federal contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price purchase order contract worth $2,010.06 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has a performance period ending on May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a range of products and services to federal...
- This $3,015.09 firm fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Jacksonville, Florida. The contract was awarded by the Defense Logistics Agency's Medical Supply Chain Division for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of December 9, 2024. The Maclean Group LLC is an ISO 9001:2015...
- This is a $2,010.06 firm fixed-price purchase order contract awarded by the Defense Department's Medical Supply Chain agency to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdoses, with a performance period ending on May 31, 2024. The Maclean Group holds several other significant federal contract...
- The U.S. government has awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the supply of naloxone hydrochloride, a critical medical product, to the Medical Supply Chain, a program under the U.S. Defense agency. This contract award is not set aside for any specific business designation. The Maclean Group LLC is an...
The U.S. Department of Defense Medical Supply Chain awarded a $2,010.06 firm fixed-price purchase order to The Maclean Group LLC for naloxone hydrochloride, with an ultimate completion date of September 24, 2025. This contract, issued on September 9, 2025, carries no set-aside designation and specifies performance at The Maclean Group's Sacramento, California location. The Maclean Group is a service-disabled veteran-owned small business (SDVOSB) and ISO 9001:2015 certified pharmaceutical and medical equipment distributor. The Maclean Group's selection for this naloxone procurement aligns with its established capabilities as a federal contractor specializing in pharmaceutical supply and medical equipment distribution across multiple government agencies. The company maintains several significant federal contract vehicles, including a $2.63 million Federal Supply Schedule contract with the Department of Veterans Affairs for medical equipment and supplies, as well as Federal Supply Schedule contracts specifically covering pharmaceuticals and in-vitro diagnostic products. This purchase order supports the Department of Defense's medical supply requirements and leverages The Maclean Group's proven track record in delivering critical pharmaceutical products to federal agencies including the VA, Department of Justice, and Naval Air Systems Command.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/9/25 |